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Background: Upper gastrointestinal bleeding of all causes has a higher morbidity and mortality in older
patients compared with younger patients. We retrospectively studied gastric variceal bleeding in older
patients and compared the complications and outcomes of endoscopic variceal obliteration with younger
patients.
Methods: From August 2002 to August 2010, a total of 76 patients with gastric variceal bleeding who had
received endoscopic variceal obliteration using Histoacryl as an adhesive agent by a single endoscopist
were studied. Their chart records were obtained and reviewed with data collection. Patient demo-
graphics, laboratory parameters, etiology of liver cirrhosis, Child-Pugh classiﬁcation, endoscopic ﬁndings,
complications after endoscopic treatment, and mortality were gathered and analyzed.
Results: A total of 26 (34.2%) of the 76 patients were older than 64 years. There were patients who were
younger than 64 years who had more variceal bleeding as compared with the older patients. In older
patient groups, women were more likely to have gastric variceal bleeding than their male counterparts.
The most common type of gastric varices was gastroesophageal varices type 2 (GOV2). Signiﬁcant
difference existed in the etiology of cirrhosis between the two groups, with more hepatitis B and
alcoholic hepatitis in the younger patients and more hepatitis C in the older patients. Signiﬁcantly more
Child-Pugh classiﬁcation B and C cases were noticed in the younger patients. There were no signiﬁcant
differences of mortality and complications after treatment, including recurrent bleeding and sepsis,
between the older and younger patients.
Conclusion: There was no signiﬁcant difference in outcomes after endoscopic treatment between the
younger and the older patient groups. Endoscopic variceal obliteration using Histoacryl as an adhesive
agent could be applied to treat older patientswith gastric variceal bleeding just as it is for younger patients.
Copyright  2012, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
Upper gastrointestinal (GI) bleeding by peptic ulcer disease or
other causes is a real challenge in older patients. It remains a major
clinical problem because elderly patients tend to have more
complications during hospitalization and mortality than younger
patients1e8. However, in one report9, researchers found the
mortality between the younger and older patients was no different,
which may be due to more younger patients having upper GI
bleeding related to portal hypertension, which raised the consid-
eration that, if upper GI bleeding is causes by portal hypertension,erest.
ion of Gastroenterology and
Memorial Hospital, Number
iwan.
hih).
iwan Society of Geriatric Emergensuch as esophageal variceal bleeding or gastric variceal bleeding, it
may have different consequences between the older and younger
patients.
Gastric varices is one of the major complications in portal
hypertensive patients with a reported incidence of about 5%e
30%10. Rupture of the gastric varices is responsible for 10%e15% of
all variceal bleeding11,12. Although bleeding from gastric varices is
less than from esophageal varices, it is often more severe and the
mortality may reach up to 20%e40%11,13, which is much higher than
the overall mortality rate of upper GI bleeding in older patients
(6%e8.9%)2,9. There is no previous study that discusses gastric
variceal bleeding between the older and younger patients, since
older patients are bearingworse outcomes than younger patients in
upper GI bleeding. So, this study was conducted to determine
whether they are the same in the gastric variceal bleeding. For this
purpose, we retrospectively reviewed the gastric variceal bleeding
patients in our hospital who had received endoscopic varicealcy & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
Table 1
Demographic and clinical patient characteristics.
Total Age group p value
<65 y 65 y
Number of patients (%) 76 50 (65.8) 26 (34.2)
Age, mean  SD (y) 59.5  12.0 52.6  7.8 72.6  6.0
Sex, n (%) 0.070
Women 33 (43.4) 18 (36.0) 15 (57.7)
Men 43 (56.6) 32 (64.0) 11 (42.3)
Etiology of cirrhosis, n (%) 0.012
Hepatitis B 25 (32.9) 17 (34.0) 8 (30.8)
Hepatitis C 18 (23.7) 11 (22.0) 7 (26.9)
Alcohol 12(15.8) 12 (24.0) 0 (0.0)
Hepatitis B þ C 1 (1.3) 0 (0.0) 1 (3.8)
Hepatitis B þ alcohol 3 (3.9) 2 (4.0) 1 (3.8)
Hepatitis C þ alcohol 4 (5.3) 3 (6.0) 1 (3.8)
Hepatitis B þ C þ alcohol 1 (1.3) 1 (2.0) 0 (0.0)
Unknown 12 (15.8) 4 (8.0) 8 (30.8)
Child-Pugh classiﬁcation, n (%) 0.016
A 20 (26.3) 8 (16.0) 12 (46.2)
B 39 (51.3) 30 (60.0) 9 (34.6)
C 17 (22.4) 12 (24.0) 5 (19.2)
Need for transfusion, n (%) 45 (59.2) 32 (64.0) 13 (50.0) 0.239
Blood transfusion (unit) 3.42  2.72 3.84  2.57 2.62  2.87 0.063
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tions and outcomes between older and younger patients.
2. Materials and methods
This is a retrospective study of consecutive patients. From
August 2002 to August 2010, a total of 76 patients with gastric
variceal bleeding who had received endoscopic variceal oblitera-
tion using an adhesive agent by a single endoscopist were studied.
Their chart records were obtained and reviewed with data collec-
tion. Patient demographics, laboratory parameters, etiology of liver
cirrhosis, Child-Pugh classiﬁcation, endoscopic ﬁndings on the
gastric varices, complications after endoscopic treatment, and
mortality were gathered and analyzed. All patients provided
written informed consent prior to undergo endoscopy. The study
protocol had been approved by the Ethics Committee for Human
Studies of Mackay Memorial Hospital Taipei, Taiwan.
Gastric varices were classiﬁed as described by Sarin and
Mishra14; they classiﬁed the gastric varices on the basis of their
location in the stomach and their relationship with esophageal
varices. Gastroesophageal varices (GOV) were classiﬁed as esoph-
ageal varices that extended below the gastroesophageal junction
with varices along the lesser curve (GOV1), along the fundus
(GOV2), isolated gastric varices (IGV) present in isolation in the
fundus (IGV1), or at ectopic sites in the stomach or the ﬁrst part of
the duodenum (IGV2).
Endoscopic variceal obliteration using an adhesive agent was
applied to treat the gastric variceal bleeding. A forward-viewing
endoscopy (Olympus, GIF Q 240 or Q 260, Tokyo, Japan) was per-
formed during the endoscopic treatment. A disposable injector
(NM 200L-0423, Olympus, Tokyo, Japan) was used for variceal
injection. The injector was rinsed with distilled water, followed by
the mixture of an adhesive agent (Histoacryl, B Braun, Melsungen,
Germany) and lipiodol (Guerbet Group, Aulnay-sous-Bois, France)
in equal amount. The mixture was put in one or two syringes
according to the desired volumes, which was calculated by endo-
scopist before variceal injection. Continuous injection was per-
formed after the needle punctured the optimal site of the varix.
Distilled water was ﬂushed through the injector only after the
entire desired amount was injected, and 1.5 to 2.0 ml of distilled
water was injected to push the remaining mixture into the injector
and into the varix. Then, we waited about 30e40 seconds and
allowed the mixture to harden. We ﬂushed the injector with
distilled water again when slowly withdrawing the injector, which
ﬁlled the needle space that has been previously impacted in the
varix; this adhered the puncture hole on the variceal mucosa. The
ﬂush solution aimed at the injection site was to be small so it did
not interfere during a possible second endoscopic treatment. We
withdrew the needle of the injector after the puncture site was
ﬂushed. Then we touched the variceal surface with the injector to
see if the varix was solid. Reinjectionwith a new injector (repeating
the same procedure) was performed if any part of the varix was
not solid. Early recurrent bleeding was deﬁned as rebleeding from
the varices within 48 hours after endoscopic treatment with
hematemesis and melena associated with a decrease of hemo-
globin more than 2 g/dl.
2.1. Statistical analysis
Descriptive statistics for continuous variables were calculated
and were reported as mean  standard deviation (SD). Four cate-
gorical variables were described using frequency distributions and
were reported as n (%). P values were based on a t-test for contin-
uous variables and Chi-Square or Fisher’s exact test was used for
categorical variables. Statistical analysis was performed using theStatistical Package for the Social Science SPSS for windows, version
12.0, SPSS Inc., Chicago, IL. Tests were two-tailed with a signiﬁcance
level of 0.05.
3. Results
Patients receiving endoscopic treatments due to gastric variceal
bleeding were included in the study from August 2002 to August
2010. Their sex and clinical characteristics at admission are pre-
sented in Table 1. A total of 26 (34.2%) of the 76 patients were older
than 64 years. There were more women in the older patient group.
There were fewer elderly patients with variceal bleeding than
younger patients (26 versus 50). Variceal bleeding in patients was
due to liver cirrhosis. Signiﬁcant difference existed in the etiologies
of cirrhosis between the two groups (p ¼ 0.012); there was more
hepatitis B and alcoholic hepatitis in younger patients and more
hepatitis C in older patients. The younger patients tended to have
severe liver cirrhosis during bleeding episodes; there were also
signiﬁcantly more Child-Pugh class B and C patients in the younger
patient group compared with the older patient group (p ¼ 0.016).
Blood transfusionwas needed in more than one-half of the patients
in both groups, but this was not a signiﬁcant difference between
two groups (p ¼ 0.239). The mean volume of blood transfusion was
3.42  2.72 unit, which is borderline signiﬁcant between the two
groups (p ¼ 0.063).
The endoscopic characteristics of patients are presented in
Table 2. The sizes of gastric varices were similar in both age groups.
The most common type of gastric varices was GOV2 in both groups;
the older patient group had more IGV1 type than the younger
patient group. However, all these ﬁndings were not statistically
signiﬁcant. Most of the patients (85.5%) had stigmata of bleeding
during endoscopic examination; conversely, 11 of the 76 patients
(14.5%) had no signiﬁcant ﬁnding on the variceal mucosa during
endoscopic examination.
The outcomes of endoscopic treatment are presented in Table 3.
Most of the patients (93.4%) received one or two endoscopic
treatments. The session of endoscopic treatment between the
younger and older patient groups had no signiﬁcant difference. The
mean volume of adhesive agent injection was 1.82 ml (range,
0.5e4.5 ml); the older patient group had a slightly higher amount
Table 2
Endoscopic patient characteristics.
Total Age group p value
<65 y 65 y
Number of patients (%) 76 50 (65.8) 26 (34.2)
Size of GV, n (%) 0.493
F1 7 (9.2) 6 (12.0) 1 (3.8)
F2 36 (47.4) 24 (48.0) 12 (46.2)
F3 or tumorous 33 (43.4) 20 (40.0) 13 (50.0)
Type of GV, n (%) 0.246
GOV1 14 (18.4) 10 (20.0) 4 (15.4)
GOV2 47 (61.8) 33 (66.0) 14 (53.8)
IGV1 15 (19.7) 7 (14.0) 8 (30.8)
IGV2 0
Stigmata of bleeding, n (%) 65 (85.5)
Spurting 1
Oozing 5
Blood clot 3
Ulcer 21
Erosion 20
Red spot 15
Normal mucosa, n (%) 11 (14.5)
GOV¼ gastroesophageal varices; GV¼ gastric varices; IOV¼ isolated gastric varices.
H.-Y. Wang et al.260of injection volume per session than the younger patient group
(1.97 ml versus 1.78 ml). There was no signiﬁcant difference in
posttreatment complications and mortality between the two
groups. Recurrent bleeding was noted in seven patients, and there
were more in the younger patient group than the older patient
group (ﬁve versus two). Sepsis developed in ﬁve patients. Big ulcer
could be found in 16 patients during follow-up endoscopy. There
was no distal embolism or damage to the scope after endoscopic
treatment. Only one endoscopic treatment failure causing death in
a woman aged 55 years of age was noted. There were four patients
who died in the older group, including liver failure in two,
cardiovascular failure in one, and respiratory failure in one. There
were four patients who died in the younger group, including liver
failure in two, respiratory failure in one, and septic shock in one.4. Discussion
Portal hypertension is mainly caused by liver cirrhosis in Taiwan
and causes the complications of collateral circulation, includingTable 3
Outcomes of endoscopic variceal obliteration.
Total Age group p value
<65 y 65 y
Number of session (%) 0.113
1 49 (64.5) 28 (56.0) 21 (80.8)
2 22 (28.9) 18 (36.0) 4 (15.4)
>2 5 (6.6) 4 (8.0) 1 (3.8)
Volume of Histoacryl per session, 1.82 1.78 1.97
ml, mean (range) (0.5e4.5) (0.5e4) (0.5e4.5)
Complication, n (%) 0.908
Immediate bleeding 0
Early rebleeding 2 (2.6) 2 (4.0) 0
Late rebleeding 5 (6.6) 3 (6.0) 2 (7.6)
Sepsis 5 (6.6) 4 (8.0) 1 (3.8)
Embolism 0
Damage to scope 0
Big ulcer post treatment 16 (21.1) 12 (24) 4 (15.4)
Treatment failure causing death 1 (1.3) 1 (2.0) 0
Other in hospital death, n (%) 8 (10.5) 4 (8.0) 4 (15.4) >0.999
Liver failure 4 2 2
Cardiovascular failure 1 1
Respiratory failure 2 1 1
Septic shock 1 1
Total in hospital death, n (%) 9 (11.8) 5 (10) 4 (15.4) 0.437gastric varices. The left gastric vein drains into the cardia and distal
esophagus, which forms the esophageal varices and GOV115. Short
gastric vein and/or posterior gastric vein, instead, form the gastric
fundal varices16.
There are multiple methods to treat gastric variceal bleeding
other than surgery, which include hemostatic tube, endoscopic
therapy, transjugular intrahepatic portosystemic shunt (TIPS), and
balloon occluded retrograde transvenous obliteration (BRTO)16e20.
Endoscopic therapy for gastric variceal bleeding includes endo-
scopic variceal ligation, which uses detachable snare or elastic
bands to ligate the varices and endoscopic variceal sclerosis, which
uses sclerosant injected into the varices16,21e25. However, there are
drawbacks in these procedures. The hemostatic tube has a high
rebleeding rate26 and causes suffering to patient during tube
insertion. TIPS has been associated with an increased incidence of
encephalopathy27; thus, its usefulness is limited by its availability
only in major centers28. BRTO is used primarily in Japan and is
unsuitable for acute gastric variceal bleeding because it needs
a spontaneous gastrorenal shunt29. Fatal bleeding has been re-
ported when a partial ligation of large gastric varices is performed
by endoscopic variceal ligation, and a high rate of rebleeding was
noticed after endoscopic variceal sclerosis21,30,31.
Randomized controlled studies have showed that endoscopic
variceal obliteration using an adhesive agent for gastric variceal
bleeding was more effective than endoscopic variceal ligation, and
variceal sclerosis has a successful hemostatic rate of 87%e93%,
a rebleeding rate of 22%e31%, and a mortality rate of 11%e29%;
compared with patients who underwent endoscopic variceal
ligation or variceal sclerosis, the corresponding rates were 45%e
93%, 25%e54%, and 15%e48%, respectively21,23. The incidence of
complications after endoscopic variceal obliteration using an
adhesive agent was low and was considered safe and effective in
the treatment of gastric variceal bleeding32e36.
During the endoscopic variceal obliteration procedure, a tissue
adhesive agent mixed with lipiodol was injected into the varix
under endoscopic guidance37e39; this mixture hardens on contact
with blood, which results in the solidiﬁcation of the gastric varices
and minimizes the risk for distal embolization or bleeding from the
puncture site32. Lipiodol prevents Histoacryl from solidifying too
quickly, decreasing the chance of damage to the endoscope and
allows the procedure be easily performed32,40e43. There is no
standard manipulation in performing the endoscopic variceal
obliteration using an adhesive agent; thus, we thoroughly
described our method of performing the variceal injection.
Our study found in the older patient group, although not
statistically signiﬁcant, there were more women who had gastric
variceal bleeding than in the younger group. There are no previous
reports that have compared gastric variceal bleeding between the
sexes; however, a similar ﬁnding was noticed in one report9, which
found that in upper GI bleeding, including esophageal variceal
bleeding, there were signiﬁcantly more women with GI bleeds in
the older group than in the younger group. There have also been
reports44 that a higher Child-Pugh score was considered a risk
factor for gastric variceal bleeding; in another report9, researchers
found that esophageal varices or gastric varices and portal hyper-
tensive gastropathy accounted for 44% of upper GI bleeding in
younger patients versus 11% in older patients. These two ﬁndings
were compatible with our results, because we found less older
patients with variceal bleeding compared with younger patients
(26 versus 50) and signiﬁcantly more Child-Pugh classiﬁcation B
and C patients were noticed in the younger patient group than in
the older patient group (p ¼ 0.016).
In our study, endoscopic examination revealed lesions of vari-
ces, including spurting, oozing, ulcer, erosion, red spot, or blood clot
coating in most of the patients (65/76, 85.5%); a similar ﬁnding was
Gastric Variceal Bleeding in the Elderly 261noticed in one study9, which reported 63 of the 90 patients with
gastroesophageal variceal bleeding had active bleeding or red
spots. GOV1 was previously considered the most common type of
gastric varices14, but, in our study, GOV2 was the most common
type in both the younger and older patient groups (Table 2). This
has also been reported in two other papers45,46.
Recurrent bleeding may be attributed to severe liver disease and
may lead to fatality. Child-Pugh classiﬁcation of B or C in cirrhotic
patients was considered as one of the risk factors in recurrent
gastric variceal bleeding between endoscopic treatment sessions47;
recurrent bleeding may also occur from incomplete obliterated
varices after endoscopic therapy9,36,46. However, the early and late
rebleeding had no signiﬁcant difference between the two groups in
our study, whichmay be due to the consistent quality in performing
the gastric variceal obliteration by a single endoscopist. Endoscopic
treatment failure causing death was noticed in one patient (1.3%),
which is compatible with previous reports6,32,34,45,47 with the range
of 0%e3.5% (Table 3). In our study, there were patients who died
during the hospitalization (themortality ratewas 11.8%), whichwas
similar to the previous report35 of 10.3% in patients with gastric
varices treated with N-butyl cyanoacrylate, and a wide range of
mortality rate has been reported (3.7%e82.5%14,45). There were no
signiﬁcant difference in the total of hospital deaths between the
older and the younger patient groups (Table 3).
Themain limitationsof this studywere its retrospectivenatureand
relatively small sample size. More well-designed prospective studies
may be needed to verify the differences between younger and older
patients of gastric variceal bleeding receiving endoscopic therapy.
In conclusion, signiﬁcantly more Child-Pugh classiﬁcations of
B and C were found in younger patients, which may lead to more
gastric variceal bleeding in this group. However, there was no
signiﬁcant difference between the younger and older patient
groups in complications and mortality after endoscopic treatment.
Thus, endoscopic variceal obliteration using Histoacryl as an
adhesive agent may be applied to treat older patients with gastric
variceal bleeding just as it is used in younger patients.
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